Rubius Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rubius Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2022.
  • Rubius Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was -$1.32M, a 114% decline year-over-year.
  • Rubius Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $15.8M, a 55.7% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.8M, a 55.7% decline from 2021.
  • Rubius Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $35.6M, a 5.78% increase from 2020.
  • Rubius Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $33.7M, a 18.4% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $15.8M -$19.8M -55.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-27
2021 $35.6M +$1.95M +5.78% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
2020 $33.7M -$7.61M -18.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $41.3M +$13.7M +49.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $27.5M +$9.63M +53.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $17.9M +$17.8M +12079% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $147K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.